e-learning
resources
ERJ
2009
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Hypersensitivity pneumonitis associated with the use of temozolomide
Koschel D., Handzhiev S., Leucht V., Holotiuk O., Fisseler-Eckhoff A., Hoffken G.
Source:
Eur Respir J 2009; 33: 931-934
Journal Issue:
April
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Koschel D., Handzhiev S., Leucht V., Holotiuk O., Fisseler-Eckhoff A., Hoffken G.. Hypersensitivity pneumonitis associated with the use of temozolomide. Eur Respir J 2009; 33: 931-934
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
HISTOLOGICAL FINDINGS IN TRANSBRONCHIAL CRYOBIOPSIES OBTAINED FROM PATIENTS AFTER COVID-19
Does “UIPAF” really exist?
Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis
Related content which might interest you:
Hypersensitivity pneumonitis associated with temozolomide
Source: Eur Respir J 2009; 33: 526
Year: 2009
Cyclophosphamide in steroid-refractory hypersensitivity pneumonitis and non-classifiable interstitial lung disease
Source: International Congress 2017 – Novel and old entities
Year: 2017
Rituximab for the treatment of chronic hypersensitivity pneumonitis
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015
Haemorrhagic hypersensitivity pneumonitis due to naphthylene-1,5-diisocyanate
Source: Eur Respir J 2002; 19: 377-380
Year: 2002
Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis
Source: ERJ Open Res, 3 (3) 00016-2017; 10.1183/23120541.00016-2017
Year: 2017
Hypersensitivity pneumonitis
Source: ERS Course 2016
Year: 2016
Hypersensitivity pneumonitis
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2018
Hypersensitivity pneumonitis
Source: Annual Congress 2004 - PG10 - Occupational and environmental disorders of the lung parenchyma
Year: 2004
Hypersensitivity pneumonitis
Source: School Course 2014 - Interstitial lung diseases
Year: 2014
Hypersensitivity pneumonitis
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019
Hypersensitivity pneumonitis
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2019
Immunotherapy and pulmonary toxicities: can concomitant immune-checkpoint inhibitors with radiotherapy increase the risk of radiation pneumonitis?
Source: Eur Respir J, 51 (1) 1701737; 10.1183/13993003.01737-2017
Year: 2018
Hypersensitivity pneumonitis caused by oral aspirin
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009
Treatment response in hypersensitivity pneumonitis
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Interstitial pneumonia vs. hypersensitivity pneumonitis with autoimmune features
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
Comparison of the clinical features of lung cancer in chronic hypersensitivity pneumonitis (CHP) and in collagen vascular disease related interstitial pneumonitis (CVD-IP)
Source: Eur Respir J 2006; 28: Suppl. 50, 675s
Year: 2006
Chronic hypersensitivity pneumonitis with familial history of interstitial lung disease
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
Idelalisib-related pneumonitis
Source: Eur Respir J 2016; 47: 1280-1283
Year: 2016
Pembrolizumab-induced pneumonitis
Source: ERJ Open Res, 3 (2) 00081-2016; 10.1183/23120541.00081-2016
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept